Maria J. Rellan-Gonzalez

Santiago De Compostela, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Weight-loss-independent actions of GLP-1 medicines.

Weight-loss-independent actions of GLP-1 medicines.

Journal: Cell metabolism

Published: June 24, 2026

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Journal: Molecular metabolism

Published: October 19, 2025

Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor.

Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor.

Journal: JCI insight

Published: October 09, 2025

The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors.

The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors.

Journal: Cell metabolism

Published: September 18, 2025

New Molecules and Indications for GLP-1 Medicines.

New Molecules and Indications for GLP-1 Medicines.

Journal: JAMA

Published: September 15, 2025

The expanding benefits of GLP-1 medicines.

The expanding benefits of GLP-1 medicines.

Journal: Cell reports. Medicine

Published: April 26, 2025

Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis.

Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis.

Journal: Cell metabolism

Published: August 06, 2024

Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice.

Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice.

Journal: Molecular metabolism

Published: February 27, 2024

Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathway.

Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathway.

Journal: Hepatology (Baltimore, Md.)

Published: August 29, 2023

Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function.

Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function.

Journal: Molecular metabolism

Published: May 24, 2023

Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions.

Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions.

Journal: Journal of biomedical science

Published: March 21, 2023

p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway.

p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway.

Journal: Cell reports. Medicine

Published: February 09, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026